Details for Patent: 7,862,833

Which drugs does patent 7,862,833 protect, and when does it expire?

Patent 7,862,833 protects FENTORA and is included in one NDA.

This patent has sixty-four patent family members in twenty-nine countries.

Summary for Patent: 7,862,833

Title:	Effervescent oral opiate dosage forms and methods of administering opiates
Abstract:	Opiate containing dosage forms and methods using same are described. These dosage forms include substantially less opiates by weight than known oral formulations. These dosage forms are intended for oral administration across the oral mucosa.
Inventor(s):	Derek Moe
Assignee:	Cephalon LLC
Application Number:	US11/026,759
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,862,833
Patent Claim Types: see list of patent claims	Composition; Compound; Delivery; Dosage form;

Drugs Protected by US Patent 7,862,833

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cephalon	FENTORA	fentanyl citrate	TABLET;BUCCAL, SUBLINGUAL	021947-001	Sep 25, 2006		DISCN	Yes	No			Y
Cephalon	FENTORA	fentanyl citrate	TABLET;BUCCAL, SUBLINGUAL	021947-002	Sep 25, 2006		DISCN	Yes	No			Y
Cephalon	FENTORA	fentanyl citrate	TABLET;BUCCAL, SUBLINGUAL	021947-003	Sep 25, 2006		DISCN	Yes	No			Y

International Family Members for US Patent 7,862,833

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	047999
Argentina	048000
Argentina	048029